120 related articles for article (PubMed ID: 1690254)
1. Cisplatin, adriamycin and ifosfamide-based combination chemotherapy for gynecological cancers derived from the extended müllerian system.
Nishida T; Nagasue N; Izumi S; Sakihama H; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):193-8. PubMed ID: 1690254
[TBL] [Abstract][Full Text] [Related]
2. Treatment of gynecological adenocarcinomas with a combination of ifosfamide, adriamycin and cisplatin.
Nishida T; Nagasue N
Nihon Sanka Fujinka Gakkai Zasshi; 1988 May; 40(5):635-9. PubMed ID: 3133435
[TBL] [Abstract][Full Text] [Related]
3. Ifosfamide, adriamycin and cisplatin (IAP) plus bleomycin (B) combination chemotherapy in patients with recurrent cancer of the uterine cervix.
Nishida T; Nagasue N; Arimatsu T; Nagano H; Izumi S; Okura N; Matsumura T; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):590-4. PubMed ID: 2474043
[TBL] [Abstract][Full Text] [Related]
4. Treatment of gynecological malignancies with a combination of cisplatin, adriamycin and ifosfamide.
Nishida T; Nagasue N; Yakushiji M
Cancer Chemother Pharmacol; 1990; 26 Suppl():S39-42. PubMed ID: 2347048
[TBL] [Abstract][Full Text] [Related]
5. [Ifosfamide combination chemotherapy for advanced gynecologic malignancies].
Li X; Liu L; Wu L
Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):330-2. PubMed ID: 11778564
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
Lund B; Hansen OP; Hansen HH; Hansen M
Semin Oncol; 1992 Feb; 19(1 Suppl 1):26-9. PubMed ID: 1411618
[TBL] [Abstract][Full Text] [Related]
7. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
Gershenson DM; Morris M; Burke TW; Levenback C; Matthews CM; Wharton JT
Obstet Gynecol; 1996 Apr; 87(4):527-31. PubMed ID: 8602303
[TBL] [Abstract][Full Text] [Related]
8. [Ifosfamide, cisplatin, adriamycin combination chemotherapy in gynecologic cancer].
Sawada M; Inagaki M; Hirota Y; Hongo J; Ozaki M
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3091-4. PubMed ID: 3674894
[TBL] [Abstract][Full Text] [Related]
9. European experience with ifosfamide in non-small cell lung cancer.
Drings P
Semin Oncol; 1989 Feb; 16(1 Suppl 3):22-30. PubMed ID: 2539645
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
11. A preliminary study of a combination chemotherapy with ifosfamide, adriamycin and cisplatin for endometrial carcinoma.
Nishida T; Nagasue N; Kishi N; Imaishi K; Tateno N; Matsumura T; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1883-8. PubMed ID: 3209914
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
[TBL] [Abstract][Full Text] [Related]
13. [The study of cyclic maintenance chemotherapy with cisplatin, adriamycin, and cyclophosphamide (cyclic PAC chemotherapy) in patients with advanced ovarian cancer].
Kobayashi H; Hayata T; Terao T; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):1936-42. PubMed ID: 2592816
[TBL] [Abstract][Full Text] [Related]
14. The role of ifosfamide in cervical cancer.
Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
Semin Oncol; 1989 Feb; 16(1 Suppl 3):60-7. PubMed ID: 2468183
[TBL] [Abstract][Full Text] [Related]
15. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
[TBL] [Abstract][Full Text] [Related]
16. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin, cisplatinum and ifosfamide infusion chemotherapy in advanced/recurrent cancer of cervix.
Singhal RM; Jindel R; Gupta AK
Indian J Cancer; 1993 Dec; 30(4):158-63. PubMed ID: 7515843
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma.
Pápai Z; Bodoky G; Szántó J; Poller I; Rahóty P; Eckhardt S; Láng I; Szendroi M
Cancer; 2000 Jul; 89(1):177-80. PubMed ID: 10897015
[TBL] [Abstract][Full Text] [Related]
20. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]